# Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes

> **NCT00380445** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 21 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Vildagliptin

## Key facts

- **NCT ID:** NCT00380445
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380445, "Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00380445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*